Meta facebook tracking pixel

Past Workshops

  1. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life
  2. Breast Cancer in Younger Women: New Treatment Options
  3. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
  4. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  5. Updates from the 46th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
  6. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
  7. Metastatic Triple Negative Breast Cancer: For Caregivers - Coping with Your Loved One's Triple Negative Breast CancerPart II of Living with Metastatic Triple Negative Breast Cancer
  8. 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
  9. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
  10. Triple Negative Breast Cancer and African American Women
  11. Metastatic Breast Cancer: Treatment Updates
  12. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  13. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
  14. Early Stage Breast Cancer: New Treatment Approaches
  15. What’s New in Precision Medicine
  16. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  17. Lobular Breast Cancer: Treatment Progress
  18. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
  19. Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
  20. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
  21. Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
  22. What’s New In Precision Medicine
  23. For Caregivers: Coping with Your Loved One’s Metastatic Triple Negative Breast CancerPart II of Living with Metastatic Triple Negative Breast Cancer
  24. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  25. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
  26. Triple Negative Breast Cancer and African American Women
  27. Metastatic Breast Cancer: Treatment Updates
  28. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  29. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
  30. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
  31. The Role of Radiation Therapy in the Treatment of Breast Cancer
  32. Metastatic Breast Cancer in African Americans: New Treatments
  33. What’s New in Diagnostic Technologies for People Living with Solid Cancer TumorsPart I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  34. Breast Cancer and Older Women
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.